Relief Therapeutics Holding AG (RLFTF)

[Vanilla Fitbit]

***** HOW MISLEADING IS THIS... SOOOO SHADY****

I JUST REALIZED ANOTHER HUGE CHANGE TO PREPRINT... WHAT A BUNCH OF SHADY SHADY INDIVIDUALS!!!!!!

****NOTICE THEY ALSO CHANGED IT FROM READING AVIPTADIL (WHICH SIGNIFIES OUR DRUG ) TO THE NEW PREPRINT VERBIAGE READS VIP!!!! SOOOOOO MISLEADING!!

NOW THEY CAN SAY THAT INDIA (FOR EXAMPLE APPROVED VIP <NOT AVIPTADIL>) SUCH MISINFORMATION, SOOOOO MISLEADING TO INVESTORS!!!!

JUST LIKE I POSTED EARLIER WHEN I SAID THEY SPECIFICALLY USED TERM ”AVIPTADIL” IN EARLIER PRINT WHICH IS OUR DRUG IN PREVIOUS MISLEADING PRE PRINT... NOW (CYA) CHANGED IT TO VIP!!

MISLEADING PRE PRINT :


“Aviptadil has been granted compassionate care authorization in the United States and Israel and has been granted Emergency Use Authorization in Georgia, Ukraine, and the Caucasus region, as well as India.”


NEW (CYA) PRE PRINT AFTER GETTING CAUGHT:

No drug has been approved for treating respiratory failure in critically ill patients with COVID-19, which remains highly lethal, despite intensive care and currently-approved antiviral and anti-cytokine drugs. Vasoactive Intestinal Peptide (VIP) has been granted Emergency Use Authorization and or Compassionate Care Authorization in multiple countries.”